Presented by the UCSF Department of Laboratory Medicine and UCSF Center for Research in Transfusion Medicine and Cellular Therapies
2023 2023 Agenda
*Schedule is tentative and is subject to change.
Cellular Therapies and Novel Blood Products in Trauma and Critical Care – The Future of Transfusion Medicine
Monday, May 8
2:00 pm-7:00 pm
Registration Desk Open – Alhambra Foyer
Badge and Materials Pick Up
4:00 pm-5:30 pm
Moderator/Speaker/Panel Briefing with A-V in Gen Session room – Alhambra Ballroom
6:30 pm-8:00 pm
Welcome Reception – Oasis Pool Bar
(Hors-d’oeurves, dinner on your own)
Tuesday, May 9 | Blood Products in Trauma and Critical Care
7:00 am-8:00 am
Breakfast – Alhambra Terrace
7:00 am-5:30 pm
Registration Desk Open – Alhambra Foyer
Badge and Materials Pick Up
8:00 am-6:00 pm
General Session – Alhambra Ballroom
8:00 am-8:10 am
Welcome & Introductions
- Shibani Pati MD, PhD
CTTACC Conference Chair
Professor of Laboratory Medicine and Surgery, UCSF
Scientific Director of Cellular Therapies
Session 1 | Whole Blood-The First Cell Therapy
This session will focus upon the pathophysiology of bleeding and coagulopathy in trauma. Focus areas will be on the utilization of whole blood in bleeding trauma patients and the optimization of resuscitation practice.
Moderator(s)
- Martin Schreiber MD, FCCM, FACS
CTTACC Conference Co-Chair
COL USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU) - John Holcomb MD, FACS
COL, USA (Ret)
Professor of Surgery, Department of Surgery
University of Alabama at Birmingham
8:10 am-8:30 am
The Pathophysiology of Trauma Induced Coagulopathy : Rationale for Whole Blood Resuscitation
- Ernest “Gene” Moore MD, FACS
Distinguished Professor of Surgery
Vice Chairman for Research
University of Colorado Denver, Anschutz Medical Campus
8:30 am-8:50 am
Adjuncts to Whole Blood (Tranexamic Acid-TXA)
- Jason Sperry MD, MPH, FACS
Section Chief, Trauma Surgery
Professor of Surgery and Critical Care
Director of Acute Care Surgery Fellowship
University of Pittsburgh
8:50 am-9:10 am
Fresh Warm Whole Blood vs Liquid Cold Stored Whole Blood/Comparisons and Differences
- Andrew (Andre) Cap MD, PhD
COL MC USA
Director of Research, US Army Institute of Surgical Research
Hematology-Oncology Consultant to the US Army Surgeon General
NATO Blood Panel Co-Chair
Professor of Medicine, Uniformed Services University
Hematology/Oncology/BMT Staff, San Antonio Military Medical Center
9:10 am-9:30 am
Can We Make DCR ‘Perfect’ Every Time? Machine Learning and Real-Time Performance Improvement to Optimize Resuscitation
- Jeremy Cannon MD, SM, FACS
Col, USAFR
Professor of Surgery
Trauma Medical Director and Section Chief of Trauma
Perelman School of Medicine, University of Pennsylvania
9:30 am-9:40 am
Question & Answer Panel | Session 1
9:40 am-10:00 am
Coffee Break – Alhambra Ballroom & Terrace
Visit Exhibits/Posters
Session 2 | Blood Shortages and Adjunctive Therapies to Reduce Blood Utilization
This session will focus on the areas of blood shortages and how to manage and optimize blood utilization. The discussion panel will debate bloodless surgery and the ethics of rationing blood products in patients.
Moderator(s)
- Beth Shaz MD, MBA
Professor and Deputy Director of Marcus Center for Cellular Cures
Duke University - Joseph Rappold MD, FACS
CAPT MC USN (Ret)
Professor of Surgery
Maine Medical Center / Tufts University
10:00 am-10:15 am
Effect of Blood Shortages on Trauma Patient Management-Blood Equity
- Martin Schreiber MD, FCCM, FACS
CTTACC Conference Co-Chair
COL USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU)
10:15 am-10:25 am
Walking Blood Banks in Times of Blood Shortages
- John Holcomb MD, FACS
COL, USA (Ret)
Professor of Surgery, Department of Surgery
University of Alabama at Birmingham
10:25 am-11:10 am
Panel Debate – Bloodless Surgery and the Ethics of Limiting Blood in Patients
Moderator(s)
- Beth Shaz MD, MBA
Professor and Deputy Director of Marcus Center for Cellular Cures
Duke University - Joseph Rappold MD, FACS
CAPT MC USN (Ret)
Professor of Surgery
Maine Medical Center / Tufts University
Panelist(s)
- Andrew (Andre) Cap MD, PhD
COL MC USA
Director of Research, US Army Institute of Surgical Research
Hematology-Oncology Consultant to the US Army Surgeon General
NATO Blood Panel Co-Chair
Professor of Medicine, Uniformed Services University
Hematology/Oncology/BMT Staff, San Antonio Military Medical Center - Pampee Young MD, PhD
Chief Medical Officer, Biomedical Services, American Red Cross, Nashville, TN
Adjunct Professor, Vanderbilt University, Cell and Developmental Biology
Adjunct Professor, Pathology, Microbiology and Immunology - Martin Schreiber MD, FACS
CTTACC Conference Co-Chair
COL USAR
Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
Oregon Health & Science University (OHSU) - Ernest “Gene” Moore MD, FACS
Distinguished Professor of Surgery
Vice Chairman for Research
University of Colorado Denver, Anschutz Medical Campus
Special Interest Talk
11:10am-11:45am
A Scientific Journey with VEGFR2 from Bench to Bedside
- Napoleone Ferrara, MD
Distinguished Professor of Pathology
Adjunct Professor of Ophthalmology and Pharmacology
UCSD
11:45 am-12:45 pm
Lunch – Valencia Lawn
Lunch – Valencia Lawn
Session 3 | Cellular and Novel Therapeutics in Neurotrauma and Polytrauma
This session will focus on novel blood and cell therapies for traumatic brain injury (TBI) and spinal cord injury (SCI). Both clinical and pre-clinical studies will be presented.
Moderator(s)
- Robert Mays PhD
Executive Vice President, Regenerative Medicine
Head of Neurosciences, Athersys, Inc - Hasan Alam MD, FACS
Chair, Department of Surgery
Loyal and Edith Davis Professor of Surgery
Professor of Surgery (Trauma and Critical Care) and Cell and Developmental Biology
Northwestern University
Surgeon-in-Chief at Northwestern Memorial Hospital
12:45 pm-1:15 pm
Clinical Trial of Bone Marrow Mononuclear Cells for Severe TBI In Children
Clinical Trial of Autologous adipose Derived MSCs for Chronic TBI
- Charles S. Cox Jr. MD, FACS
The George and Cynthia Mitchell Distinguished Chair in Neurosciences
Director, Children’s Program in Regenerative Medicine
Professor, Department of Pediatric Surgery
UTHealth Houston
1:15 pm-1:35 pm
Plasma for the Treatment of TBI: A Prospective Randomized Clinical Trial
- Hasan Alam MD, FACS
Chair, Department of Surgery
Loyal and Edith Davis Professor of Surgery
Professor of Surgery (Trauma and Critical Care) and Cell and Developmental Biology
Northwestern University
Surgeon-in-Chief at Northwestern Memorial Hospital
1:35 pm-1:55 pm
Clinical Trials of Stem Cells in Spinal Cord Injury
- James Guest MD, PhD
Clinical Professor, Department of Neurological Surgery
Miller School of Medicine and Miami Project to Cure Paralysis
University of Miami
1:55 pm-2:15 pm
Treating the Endotheliopathy of TBI with Novel Platelet Products
- Shibani Pati MD, PhD
CTTACC Conference Chair
Professor of Laboratory Medicine and Surgery, UCSF
Scientific Director of Cellular Therapies
2:15 pm-2:35 pm
Question & Answer | Session 3
2:35 pm-2:50 pm
Coffee Break – Alhambra Ballroom & Terrace
Visit Exhibits/Posters
Session 4 | Platelet Biology and Novel Blood Products in Health and Disease
This session will discuss the pathophysiology of platelet and endothelial function in health and disease. Advances in novel platelet products and oxygen carriers will be presented.
Moderator(s)
- Mike Fitzpatrick PhD
COL USA (Ret)
Chief Scientific Officer
Cellphire Therapeutics, Inc. - Ernest “Gene” Moore MD, FACS
Distinguished Professor of Surgery
Vice Chairman for Research
University of Colorado Denver, Anschutz Medical Campus
2:50 pm-3:10 pm
Platelet Biogenesis in The Lung and Spleen During Homeostasis and Injury
- Mark R. Looney MD
Professor of Medicine and Laboratory Medicine
University California San Francisco
3:10 pm-3:30 pm
Synthetic Platelets for Use in Trauma and Hemorrhage
- Anirban Sen Gupta PhD
Professor
Case Western University, Biomedical Engineering
Cleveland
3:30 pm-3:50 pm
Microvascular Thrombosis – Innate Immune Signals that Drive Platelet Function
- Matthew Neal MD, FACS
Roberta G. Simmons Associate Professor of Surgery
Co-Director, Trauma and Transfusion Medicine Research Center
University of Pittsburgh
3:50 pm-4:10 pm
Intro to Whole Blood Substitute-DARPA
- Jean-Paul Chretien MD, PhD
CDR MC USN
Program Manager
Biological Technologies Office
Defense Advanced Research Projects Agency (DARPA)
4:10 pm-4:30 pm
Synthetic Biology Meets Bio-Inspired Engineering: Path to a Whole Blood Analogue
- Allan Doctor MD
Professor of Pediatrics and Bioengineering
Director, Center of Blood Oxygen Transport and Hemostasis
CSO and Founding Partner, KaloCyte
4:30 pm-4:50 pm
Artificial Oxygen Carriers: Can We Use Them Now?
- Jonathan Jahr MD, PhD, DABA, FASA
Professor Emeritus of Anesthesiology and Perioperative Medicine
David Geffen School of Medicine at UCLA
Ronald Reagan UCLA Medical Center
4:50 pm-5:10 pm
A Journey in Understanding Post-Injury Platelet Behavior
- Lucy Kornblith MD, FACS
Assistant Professor of Surgery and Lab Medicine, UCSF
Division of General Surgery
Trauma and Surgical Critical Care
Zuckerberg San Francisco General Hospital
5:10 pm-5:20 pm
Question & Answer Panel | Session 4
Special Interest Talk
5:20 pm-5:40 pm
Military Medical Research Making a Difference
- Terry M. Rauch PhD, MPH, MBA
Director of Medical Research and Development Health Readiness Policy & Oversight OASD(HA)
Defense Health Headquarters
5:40 pm-5:50 pm
Moderator Q&A – John Holcomb MD, FACS
5:50 pm-7:00 pm
Reception – Kasbah Patio
7:00 pm-7:10 pm
Introduction of Keynote Speaker – Castillo Lucena
- Kenneth Bertram MD, PhD
Co-Chair CTTACC
COL MC USA (Ret)
Clinical Product Development Officer
Wake Forest University
7:10 pm-7:40 pm
2023 Keynote
From Maricao to Scottsdale
- HON Lester Martinez-Lopez MD
Assistant Secretary of Defense for Health Affairs
7:40 pm-9:00 pm
Dinner – Cortijo Plaza
Wednesday, May 10 | Regenerative Medicine and Cell Therapies for Trauma and Critical Care Medicine. Addressing Threat X (BARDA)
7:00 am-8:00 am
Breakfast – Alhambra Terrace
7:00 am-5:30 pm
Registration Desk Open – Alhambra Foyer
Badge and Materials Pick Up
8:00 am-8:05 am
Welcome & Introductions
- Shibani Pati MD, PhD
CTTACC Conference Chair
Professor of Laboratory Medicine and Surgery, UCSF
Scientific Director of Cellular Therapies
Session 5 | Novel Cell Therapies and Blood Products for the Treatment of COVID-19
This session will discuss the pathophysiology of COVID-19 as well as pre-clinical and clinical data on novel therapies (cell and blood) that have been investigated to mitigate outcomes in COVID-19 patients.
Moderator(s)
- Andrew (Andre) Cap MD, PhD
COL MC USA
Director of Research, US Army Institute of Surgical Research
Hematology-Oncology Consultant to the US Army Surgeon General
NATO Blood Panel Co-Chair
Professor of Medicine, Uniformed Services University
Hematology/Oncology/BMT Staff, San Antonio Military Medical Center
- Raymond P. Goodrich, PhD
Executive Director, Infectious Disease Research Center
Office of the Vice President for Research
Professor, Department of Microbiology, Immunology and Pathology
Colorado State University
8:05 am-8:25 am
Immune Cell Activation in COVID-19
- Clifford Lowell MD
Distinguished Professor and Chair of Department of Laboratory Medicine
University of California, San Francisco
8:25 am-8:45 am
Novel Extracorporeal Therapies for the Treatment of COVID-19… and Beyond
- Kevin Chung MD
COL MC USA (Ret)
CMO SeaStar Medical
8:45 am-9:05 am
Impact of COVID-19 in the Deployed Setting-Lessons Learned
- Jennifer Gurney MD, FACS
Chief, Joint Trauma System
COL MC USA
US Army Institute of Surgical Research
Fort Sam Houston
9:05 am-9:25 am
MSCs in ARDS due to COVID-19, a Randomised Clinical Trial- the REALIST Trial
- Danny McAuley MD
Professor and Consultant in Intensive Care Medicine
Queen’s University of Belfast and Royal Victoria Hospital, Belfast
9:25 am-9:45 am
Allogeneic Off-the-Shelf CAR NK Cell Therapy for Treating COVID-19 and Cancer
- Jianhua Yu PhD
Professor in the Department of Hematology & Hematopoietic Cell Transplantation
City of Hope
9:45 am-10:05 am
Bone Marrow MSCs in Acute COVID-19 Data from a Multi-Center, Randomized Placebo Controlled Clinical Trial (STAT)
- Michael Matthay MD
Professor of Pulmonary Critical Care Medicine
Research Lab Director, Acute Lung Injury and ARDS: Research and Clinical Trials
Critical Care Specialist
University of California San Francisco
10:05 am-10:25 am
Coffee Break – Alhambra Ballroom & Terrace
Visit Exhibits/Posters
10:25 am-10:45 am
Covid Convalescent Plasma for the Treatment of COVID-19 Patients
- Michael J. Joyner MD
Caywood Professor of Anesthesiology
Department of Anesthesiology & Perioperative Medicine
Mayo Clinic
10:45 am-11:05 am
Real World Data-Lessons Learned from CCP for COVID-19 (Virtual)
- Peter Marks MD, PhD
Director of the Center for Biologics Evaluation and Research
US FDA
11:05 am-11:15 am
Question & Answer Panel | Session 5
Session 6 | One Health Driving Translational Development for Novel Therapeutics
This session will explore the concept of One Health investigation in animals and how these studies can drive and advance translation of novel therapies to humans.
Moderator
- Heather Pidcoke MD, PhD
Chief Medical Research Officer, OVPR
Joint Faculty, Dept. Clinical Sciences, CVMBS
Colorado State University - Timothy Hackett DVM
Alexander de Lahunta Chair, Department of Clinical Sciences
Professor of Emergency and Critical Care Medicine
College of Veterinary Medicine
Cornell University
11:15 am-11:30 am
One Health Driving Translational Development: The University Perspective
- Tracy Webb DVM, PhD
Research Scientist
Colorado State University
11:30 am-11:45 am
One Health Driving Translational Development: The FDA Perspective
- Lynne Boxer DVM
Veterinary Medical Officer FDA
Office of new Animal Drug Evaluation
11:45 am-12:00 pm
What is this Veterinary Data doing in My BLA? HBOCs/Lyophilized Blood Products/Stem Cells
- Anne S. Hale DVM
Chief Development Officer
Personalized Stem Cells
12:00 pm-12:15 pm
Initiatives in Veterinary Trauma: A Model for RDCR In Austere Environments
- Kelly Hall
DVM, MS, DACVECC
Associate Professor, Critical Care Services
Colorado State University
Executive Director, ACVECC VetCOT
12:15 pm-12:25 pm
Question & Answer Panel | Session 6
12:25 pm-1:25 pm
Lunch – Valencia Lawn
1:25 pm-1:35 pm
CTTACC Transfusion Medicine Award Presentation
Session 7 | Regenerative Medicine and Stem Cells for Trauma and Critical Care
This session will focus on a number of regenerative and reparative approaches to mitigating outcomes in trauma and critical care medicine. CAR-T cell technology and advances will be discussed in the context of how they may be of potential use in injury and other diseases.
Moderator(s)
- James Guest MD, PhD
Professor of Neurological Surgery
University of Miami, Miller School of Medicine - Michael Matthay MD
Professor of Pulmonary Critical Care Medicine
Research Lab Director, Acute Lung Injury and ARDS: Research and Clinical Trials
Critical Care Specialist
University of California, San Francisco
1:35 pm-1:55 pm
Enabling Technologies for Stem Cell Delivery to Wounds
- Geoffrey Gurtner MD, FACS
Chair, Department of Surgery
Professor, Surgery
Professor, Biomedical Engineering
University of Arizona College of Medicine
1:55 pm-2:15 pm
Regenerating and Repairing Organ Damage Induced by Severe Injury with Novel Cryoprecipitate Products
- Rosemary Kozar MD, FACS
Professor, Surgery, Dept of Surgery
Director of Translational Research, Shock Trauma Center
Co-Director of STAR-ORC
University of Maryland Baltimore
2:15 pm-2:35 pm
Extracellular Vesicles: Communicators and Carriers of Therapeutic Cargo in Trauma
Extracellular Vesicles: Communicators and Carriers of Therapeutic Cargo in Trauma
- Alpa Mahuvakar PhD
Research Professor
University California San Francisco
2:35 pm-2:55 pm
Bioprocessing and Ex Vivo Therapeutic Use of Mesenchymal Stromal Cells for Renal Repair
- Biju Parekkadan PhD
Associate Professor, Biomedical Engineering,
Rutgers University
2:55 pm-3:15 pm
OMX, A Novel Oxygen Delivery Biotherapeutic for Treatment of Hemorrhagic Shock
- Emin Maltepe, MD
Professor Department of Pediatrics and Neonatology UCSF
3:15 pm-3:35 pm
Nanobody-Based CAR-T Cells and Potential Applications
- Arun Wiita MD, PhD
Associate Professor, Department of Laboratory Medicine, UCSF
Assistant Director, UCSF Clinical Cytogenetics Laboratory
Director, UCSF Stephen and Nancy Grand Multiple Myeloma Translational Initiative Laboratory
3:35 pm-3:55 pm
The Development of Smarter CART-T Cells
- Francesco Marincola MD
Chief Scientific Officer
Sonata Therapeutics, Inc.
3:55 pm-4:05 pm
Question & Answer Panel | Session 7
4:05 pm-4:20 pm
Coffee Break– Alhambra Ballroom & Terrace
Visit Exhibits/Posters
4:20 pm-4:40 pm
Antimicrobial Properties of Stem Cells in Wound Healing
- Steve Dow DVM, PhD
Professor of Immunology
Director of the Center for Immune and Regenerative Medicine
Colorado State University
4:40 pm-4:55 pm
Human Placental Stem Cell-Based Combination Therapies for Prevention of Abdominal Adhesions
- Samuel Carmichael, MD
Assistant Professor of Surgery
Wake Forest School of Medicine – Baptist Medical Center
North Carolina
4:55 pm-5:15 pm
Vascular Regeneration with Human Acellular Vessels
- Luigi Pascarella, MD, FACS
Professor of Surgery
Vice Chair for Diversity, Equity, and Inclusion
Director of Surgery Clerkship
Division of Vascular Surgery
Department of Surgery
The University of North Carolina at Chapel Hill
5:15 pm-5:25 pm
Question & Answer Panel | Session 7
Session 8 | Product Development for Disaster Medicine – Threat X
This session with discuss countermeasures for a variety of mass disasters.
Moderator(s)
- Mary Homer, PhD
Chief United States Radiological and Nuclear Countermeasures,
Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
Biomedical Advanced Research and Development Authority (BARDA) - Mitchell Cohen MD, FACS
Professor of Surgery and Vice Chair of Research
University of Colorado
5:25 pm-5:40 pm
A Threat Agnostic Approach to Treating Injuries with Host Directed Therapeutics
- Kimberly Hofmeyer, PhD
Department of Health and Human Services
BARDA
5:40 pm-5:55 pm
Animal Model Considerations for Development of Blood Products to Prevent, Mitigate, or Treat “Threat X”
- Isabel Lauren Jackson, PhD
Founding Principal
True North BioPharma, LLC - Melanie Doyle-Eisele, PhD
Senior Director Life Sciences/Laboratory Animal Sciences at Lovelace Biomedical
5:55 pm-6:10 pm
Development of Countermeasures to Address Threat X Using Human Organ Chips
- David Chou MD, PhD
Clinical Fellow, Ingber Lab
Wyss Institute for Biologically Inspired Engineering at Harvard University
6:10 pm-6:25 pm
The Biology of Threat X: Coagulation, Inflammation, Immune and Endothelial Perturbations After Critical Injury and Illness. Implications for Generalized Countermeasures and Personalized Medicine
- Mitchell Cohen, MD
Professor of Surgery and Vice Chair of Research
University of Colorado
6:25 pm- 6:35 pm
Question & Answer Panel | Session 8
6:35 pm-7:35 pm
Reception – Valencia Lawn
7:35 pm-10:00 pm
Dinner – Valencia Lawn
CTTACC Awards Presentation
Thursday, May 11 | Clinical Trial Design, Product Development and Sustaining Funding for Research
7:00 am-8:00 am
Breakfast – Alhambra Terrace
7:00 am-12:00 pm
Registration Desk Open – Alhambra Foyer
Badge and Materials Pick Up
8:00 am-8:05 am
Welcome & Introductions
- Heather Pidcoke MD, PhD
Chief Medical Research Officer, OVPR
Joint Faculty, Dept. Clinical Sciences, CVMBS
Colorado State University
Special Interest Talk
8:05am-8:25am
Platelets Made In Vitro: Opportunities and Challenges
- Cédric Ghevaert MD, PhD, FRCP, FRCPath
Professor of Transfusion Medicine
University of Cambridge
Consultant Haematologist
NHS Blood and Transplant
Session 9 | Optimizing Clinical Trial Design to Support Advancement of Novel Therapies and Critical Care Medicine
Moderator(s)
- Jason Sperry MD, MPH, FACS
Section Chief, Trauma Surgery
Professor of Surgery and Critical Care
Director of Acute Care Surgery Fellowship
University of Pittsburgh - Charles S. Cox Jr. MD, FACS
The George and Cynthia Mitchell Distinguished Chair in Neurosciences
Director, Children’s Program in Regenerative Medicine
Professor, Department of Pediatric Surgery
UTHealth Houston
8:25 am-8:45 am
Resuscitating (with) Thomas Bayes
- Jan Jansen MBBS, PhD, FRCS
Professor | Division of Trauma & Acute Care Surgery
Director | Center for Injury Science
Associate Vice Chair for Clinical Trials | Department of Surgery
University of Alabama at Birmingham
8:45 am-9:05 am
Adaptive Platform Clinical Trial Design
- Roger J. Lewis MD, PhD
Senior Medical Scientist, Berry Consultants, LLC
Investigator, The Lundquist Institute
Professor of Medicine, David Geffen School of Medicine at UCLA
9:05 am-9:25 am
Sex Differences as Critical Considerations in Pre-Clinical and Clinical Development Pathways – What Took Us So Long?
- Laura Ruse Brosch RN, PhD
COL ANC USA (ret)
Assistant Vice President for Research Initiatives and Compliance
Uniformed Services University of the Health Sciences
9:25 am-9:45 am
Long-term Outcomes Research in Trauma and Critical Care Medicine
- Joe Cuschieri, MD
Professor of Surgery and Lab Medicine
Interim Chief of Surgery
Trauma Medical Director at Zuckerberg San Francisco General Hospital and Trauma Center
University of California San Francisco
9:45 am-10:05 am
The Evidence on Hemostatic Resuscitation for Children with Life Threatening Bleeding
- Phil Spinella, MD, FCCM
USA
Professor in the Departments of Surgery and Critical Care Medicine
Co-Director of the Trauma and Transfusion Medicine Research Center
Associate Medical Director of the Center for Military Medicine Research
University of Pittsburgh
10:05 am-10:15 am
Question & Answer Panel | Session 9
10:15 am-10:30 am
Coffee Break – Alhambra Ballroom & Terrace
Exhibits closed and dismantled
Special Interest Talk
10:30 am-10:50 am
The Therapeutic Potential for Integrative Medicine in Acute and Chronic Illness
- Virginia Von Schaefer MD
Medical Director
Integrative Oncology & Medicine Clinic – VVS MD, CA
10:50 am-11:00 am
Moderator Q&A – Shibani Pati, MD
Session 10 | Funding and Sustainability of Research Panel
This session will be focused on funding and sustainability of support for novel therapeutics in trauma and critical care. Points of discussion will include how to fund Phase 3 trials, how to advance translation to patients, and how to sustain research funding and support in this field through industry and federal agency partnerships.
Moderator(s)
- Kenneth Bertram MD, PhD
Co-Chair CTTACC
COL MC USA (Ret)
Clinical Product Development Officer
Wake Forest University - Heather Pidcoke MD, PhD
Chief Medical Research Officer, OVPR
Joint Faculty, Dept. Clinical Sciences, CVMBS
Colorado State University
11:00 am-11:15 am
Funding Through MRMC
- Travis Polk, MD
Director, DoD Combat Casualty Care Research Program
CAPT USN
Chair, Joint Program Committee-6
Director, Combat Casualty Care Research Program (CCCRP)
US Army Medical Research and Development Command (USAMRDC)
Defense Health Agency
Ft Detrick, MD
11:15 am-11:45 am
Panel Discussion
- Travis Polk, MD
Director, DoD Combat Casualty Care Research Program
CAPT USN
Chair, Joint Program Committee-6
Director, Combat Casualty Care Research Program (CCCRP)
US Army Medical Research and Development Command (USAMRDC)
Defense Health Agency
Ft Detrick, MD - Mary Homer, PhD
Chief United States Radiological and Nuclear Countermeasures,
Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
Biomedical Advanced Research and Development Authority (BARDA) - Melinda Hamer MD, MPH, FACEP
Deputy Director, Operations
LTC USA
Congressionally Directed Medical Research Programs
Associate Professor of Military and Emergency Medicine at Uniformed Service University - Keith Hoots MD
Session 11 | Challenges of Product Development Talk Panel
This session will focus on the challenges of product development for novel cell therapies and blood products.
Moderator(s)
- Becky Cap MBA
SVP, Business Development, Advanced Therapies
BioBridge Global - Mary Homer, PhD
Chief United States Radiological and Nuclear Countermeasures,
Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
Biomedical Advanced Research and Development Authority (BARDA)
11:45 am-12:05 pm
Challenges of Cell Therapy Product Development
- Fabio Triolo D.d.R., M.Phil., PhD
The Clare A. Glassell Distinguished Chair
Director, Cellular Therapy Core
Professor, Department of Pediatric Surgery
UTHealth Houston
12:05 pm-12:25 pm
Challenges of Novel Blood Product Development
- Lisa Buckley MPH
Director of Clinical Trials and Regulatory Affairs, Velico Inc.
OHSU Center for Regenerative Medicine
12:25 pm-12:45 pm
Challenges with Manufacturing Mesenchymal Stromal Cells for Clinical Trials
- David Stroncek MD
Director, Center for Cellular Engineering, National Institutes of Health
12:45 pm- 1:00 pm
Overcoming Challenges in the Cellular Therapy Laboratory
- Patrick Hanley PhD
Chief & Director, Cellular Therapy Program
Associate Professor of Pediatrics
Children’s National Hospital
The George Washington University
1:00 pm- 1:20 pm
Concluding Remarks
- Shibani Pati MD, PhD
CTTACC Conference Chair
Professor of Laboratory Medicine and Surgery, UCSF
Scientific Director of Cellular Therapies - Heather Pidcoke MD, PhD
Chief Medical Research Officer, OVPR
Joint Faculty, Dept. Clinical Sciences, CVMBS
Colorado State University
1:20 pm-2:00 pm
Lunch – Alhambra Terrace
Conference Adjourns
SIGNUP FOR MORE INFORMATION
Questions? Email us at [email protected] or call 303-238-0685